ARG23874

Goat anti-Human IgG (Fc) antibody (HRP), pre-adsorbed

Goat anti-Human IgG (Fc) antibody (HRP), pre-adsorbed for ELISA,FLISA,Flow cytometry,Western blot and Human

publication_link Publication5

Overview

Product Description HRP-conjugated Goat Polyclonal antibody recognizes Human IgG (Fc)
Tested Reactivity Hu
Species Does Not React With Ms, Rat, Bov, Chk, Goat, Gpig, Hm, Hrs, Rb, Sheep
Tested Application ELISA, FACS, FLISA, WB
Specificity Reacts with the Fc region of human IgG. Minimal reaction to Fab region of human IgG and other human immunoglobulins. Minimal cross reactivity with bovine, mouse, horse, rat, goat, sheep, rabbit, hamster, chicken, and guinea pig serum proteins.
Host Goat
Clonality Polyclonal
Isotype IgG
Target Name IgG (Fc)
Antigen Species Human
Immunogen Human IgG
Conjugation HRP

Application Instructions

Pre Adsorbed Human IgG Fab, IgM, and IgA; Rabbit, mouse, rat, bovine, horse, hamster, goat, sheep, chicken, and guinea pig serum proteins.
Application Suggestion
Tested Application Dilution
ELISA1:4000 - 1:8000
FACSAssay-dependent
FLISAAssay-dependent
WBAssay-dependent
Application Note * The dilutions indicate recommended starting dilutions and the optimal dilutions or concentrations should be determined by the scientist.

Properties

Form Liquid
Purification Affinity purification with immunogen.
Buffer PBS (pH 7.4) and 50% Glycerol.
Stabilizer 50% Glycerol
Storage Instruction Aliquot and store in the dark at 2-8°C. Keep protected from prolonged exposure to light. Avoid repeated freeze/thaw cycles. Suggest spin the vial prior to opening. The antibody solution should be gently mixed before use.
Note For laboratory research only, not for drug, diagnostic or other use.

Specific References

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19

ELISA / 

Chan Mi Lee et al.
Front Immunol.,  (2023)

publication_link

 

hr_line

Distinct Immune Response at 1 Year Post-COVID-19 According to Disease Severity

ELISA / 

Chang Kyung Kang et al.
Front Immunol.,  (2022)

publication_link

 

hr_line

Persistent Antibody Responses up to 18 Months after Mild SARS-CoV-2 Infection

ELISA / 

Pyoeng Gyun Choe et al.
J Infect Dis.,  (2022)

publication_link

 

hr_line

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

ELISA / 

Jinyong Kim et al.
Front Immunol,  (2022)

publication_link

 

hr_line

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection

ELISA / 

Chang Kyung Kang et al.
BMC Med.,  (2022)

publication_link

 

hr_line